Zolpidem, a valuable alternative to benzodiazepine hypnotics for chronic insomnia?

Journal of International Medical Research

Volumn 27, Issue 6, 1999, Pages 253-263

  Declerck, A ^a   Smits, M ^b  

^a Centre for Sleep Wake Disorders   (Netherlands)

^b Department of Neurology ^*  (Netherlands)

Author keywords

Benzodiazepines; Chronic insomnia; Polysomnography; Subjective evaluation; Zolpidem

Indexed keywords

BENZODIAZEPINE; FLURAZEPAM; LOPRAZOLAM; LORMETAZEPAM; MIDAZOLAM; NITRAZEPAM; OXAZEPAM; TEMAZEPAM; ZOLPIDEM;

ADULT; AGED; ANXIETY; ANXIETY NEUROSIS; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; INSOMNIA; MALE; POLYSOMNOGRAPHY; QUALITY CONTROL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLEEP;

EID: 0033492693     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059902700601     Document Type: Article

References (29)

1. Gillin JC, Byerley WF: The diagnosis and management of insomnia. N Engl J Med 1990; 322: 239-248.
2. Sloan EP, Shapiro CM: Editorial. J Psychosom Res 1985; 42: 225-232.
3. Mellinger GD, Balter MB, Uhlenhuth EH: Insomnia and its treatment. Arch Gen Psychiatry 1985; 42: 225-232.
4. Walsh JK, Engelhardt CL: Trends in the pharmacologic treatment of insomnia. J Clin Psychiatry 1992; 53 (Suppl 12): 10-17.
5. Roth T, Roehrs TA: Issues in the use of benzodiazepine therapy. J Clin Psychiatry 1992; 53 (Suppl 6): 14-18.
6. Declerck AC, Ruwe F, O'Hanlon JF, et al: Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia. Psychopharmaology (Berl) 1992; 106: 497-501.
7. Perrault G, Morel E, Sanger DJ, et al: Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 1990; 187: 487-494.
8. Langer SZ, Arbilla S: Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes. Fundam Clin Pharmacol 1988; 2: 159-170.
9. Zivkovic B, Perrault G, Sanger DJ: Relevance of intrinsic activity and receptor selectivity for the development of tolerance and physical dependence after repeated administration of benzodiazepines. In: Current Therapeutic Approaches to Panic and Other Anxiety Disorders. Vol 8 (Darcourt G, Mendlewicz J, Racagni G, Brunello N, eds). International Academy for Biomedical and Drug Research. Basel: Karger 1994; pp138-143.
10. Dockhorn RJ, Dockhorn DW: Zolpidem in the treatment of short-term insomnia: a randomized, double blind, placebo-controlled clinical trial. Clin Neuropharmacol 1996; 19: 333-340.
11. Scharf MB, Roth T, Vogel GW, et al: A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994; 55: 192-199.
12. Herrmann WM, Kubicki ST, Boden S, et al: Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation. J Int Med Res 1993; 21: 306-322.
13. Monti JM, Attali P, Monti D, et al: Zolpidem and rebound insomnia - a double, blind, controlled polysomnographic study. Pharmacopsychiatry 1994; 27: 166-175.
14. Silvestri R, Ferrillo F, Murri C, et al: Rebound insomnia after abrupt discontinuation of hypnotic treatment: double-blind, randomized comparison of zolpidem versus triazolam. Hum Psychopharmacol 1996; 11: 225-233.
15. Ware JC, Walsk JK, Scharf MB, et al: Minimal rebound insomnia after treatment with 10-mg zolpidem. Clin Neuropharmacol 1997; 20: 116-125.
16. Lader M: Rebound insomnia and newer hypnotics. Psychopharmacol 1992; 108: 248-255.
17. Knuistingh Neven A, Lemmens CPJM: Zopiclon en zolpidem: aanwinst of meer van hetzelfde? (in German). Geneesmiddelen Bulletin 1999; 33: 13-17.
18. Rechtschaffen A, Kales A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Dept of Health, Education and Welfare Public Health Service. Bethesda: National Institute of Health, 1968.
19. Van Diest R, Milius H, Markusse R, et al: De Slaap-Waak Ervaring lijst (in German). Tijdschrift Sociale Gezondheidszorg. 1989; 67: 343-347.
20. Bech P, Malt UF, Dencker SJ, et al. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand Suppl 1993; 87 (372): 1-87.
21. Snedecor GW, Cochran WG: Statistical Methods, 7th edn: Iowa State University Press, 1980.
22. Gaillard JM: Neurotransmitters and sleep pharmacology. In: Handbook of Sleep Disorders (Thorpy MJ, ed). New York: Marcel Dekker Inc., 1990; pp55-76.
23. Tyrer P: Withdrawal from hypnotic drugs. BMJ 1993; 306: 706-708.
24. Mendelson BW: Hypnotics in the treatment of chronic insomnia. In: Handbook of Sleep Disorders (Thorpy MJ, ed). New York: Marcel Dekker Inc., 1990; pp737-753.
25. Stephens DN, Sanger DJ: The abuse and dependence liabilities of zolpidem. In: Zolpidem: an Update of its Pharmacodynamic Properties and Therapeutic Place in the Management of Insomnia (Freeman H, Puech AJ, Roth T, eds). Paris: Elsevier, 1996; pp73-86.
26. Benavides J, Abadie P, Baron JC, et al: In vivo interaction of zolpidem with ω (benzodiazepine) site subtypes. In: Zolpidem: an Update of its Pharmacodynamic Properties and Therapeutic Place in the Management of Insomnia. (Freeman H, Puech AJ, Roth T, eds). Paris: Elsevier, 1996; pp33-43.
27. Horne J: Why We Sleep. Oxford: Oxford Medical Publications, 1989.
28. Kupfer DJ, Reynolds CF: Management of insomnia. N Engl J Med 1997; 336: 341-346.
29. Morin CM, Culbert JP, Schwartz SM: Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994; 151: 1172-1180.